These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1915525)
1. High dose intravenous gamma-globulin in intractable epilepsy of childhood. Etzioni A; Jaffe M; Pollack S; Zelnik N; Benderly A; Tal Y Eur J Pediatr; 1991 Jul; 150(9):681-3. PubMed ID: 1915525 [TBL] [Abstract][Full Text] [Related]
2. Immune globulin treatment in intractable epilepsy of childhood. Türkay S; Baskin E; Dener S; Gültekin A; Tanzer F; Sekreter E Turk J Pediatr; 1996; 38(3):301-5. PubMed ID: 8827898 [TBL] [Abstract][Full Text] [Related]
3. [Malignant epilepsy in children: therapy with high doses of intravenous immunoglobulin]. Sterio M; Gebauer E; Felle D; Vucicević G; Zalisevskij G Med Pregl; 1992; 45(5-6):220-4. PubMed ID: 1365062 [TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study. van Engelen BG; Renier WO; Weemaes CM; Strengers PF; Bernsen PJ; Notermans SL Eur J Pediatr; 1994 Oct; 153(10):762-9. PubMed ID: 7813537 [TBL] [Abstract][Full Text] [Related]
5. [Intravenous immunoglobulin in the treatment of malignant epilepsy in children]. Sterio M; Gebauer E; Vucicević G; Zalisevskij G; Felle D; Kolarov N Wien Klin Wochenschr; 1990 Apr; 102(8):230-3. PubMed ID: 2111611 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immune globulin in the treatment of intractable childhood epilepsy. Duse M; Notarangelo LD; Tiberti S; Menegati E; Plebani A; Ugazio AG Clin Exp Immunol; 1996 May; 104 Suppl 1():71-6. PubMed ID: 8625548 [TBL] [Abstract][Full Text] [Related]
7. [3 case reports of patients with malignant epilepsy treated with high doses of intravenous immunoglobulin]. Sterio M; Gebauer E; Vucićević G; Zalisevskij G; Felle D; Kolarov N Med Pregl; 1989; 42(9-10):332-4. PubMed ID: 2636331 [TBL] [Abstract][Full Text] [Related]
15. [Personal experience in the treatment of malignant epilepsies in children using high doses of intravenous immunoglobulins]. Sterio M; Gebauer E; Fellé D; Vucićević G Med Pregl; 1988; 41(7-8):305-8. PubMed ID: 3150032 [No Abstract] [Full Text] [Related]
16. The use of immunoglobulins in the treatment of human epilepsy. Villani F; Avanzini G Neurol Sci; 2002 Apr; 23 Suppl 1():S33-7. PubMed ID: 12032585 [TBL] [Abstract][Full Text] [Related]
17. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Toledano M; Britton JW; McKeon A; Shin C; Lennon VA; Quek AM; So E; Worrell GA; Cascino GD; Klein CJ; Lagerlund TD; Wirrell EC; Nickels KC; Pittock SJ Neurology; 2014 May; 82(18):1578-86. PubMed ID: 24706013 [TBL] [Abstract][Full Text] [Related]
18. IgG2 deficiency and intractable epilepsy of childhood. Duse M; Tiberti S; Plebani A; Avanzini MA; Gardenghi M; Menegati E; Monafo V; Ugazio AG Monogr Allergy; 1986; 20():128-34. PubMed ID: 3773903 [TBL] [Abstract][Full Text] [Related]
19. Effects of gamma-globulin therapy in severely epileptic children. Bedini R; de Feo MR; Orano A; Rocchi L Epilepsia; 1985; 26(1):98-102. PubMed ID: 2578954 [TBL] [Abstract][Full Text] [Related]
20. Breaking the cycle: A comparison between intravenous immunoglobulins and high dosage prednisone in the treatment of medically intractable epilepsy in children. Tang-Wai R; Mailo J; Rosenblatt B Seizure; 2017 Apr; 47():34-41. PubMed ID: 28284046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]